It would, therefore, be logical to consider that in certain higher-risk groups i.e. with higher incidence rates of significant PrCa, such as in men with African and African Caribbean ancestry, the development of a targeted screening programme utilising PSA and other tools including genetic polygenic risk scores may be justified [49]. This evidence concerns the gene KLK3 and pure red-cell aplasia.